Automated Dialysis Anemia Management: Role of the Treating Nephrologist
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Fuertinger D, Wang L, Jorg D, Fuentes L, Ye X, Casper S
. Effects of Individualized Anemia Therapy on Hemoglobin Stability: A Randomized Controlled Pilot Trial in Patients on Hemodialysis. Clin J Am Soc Nephrol. 2024; .
PMC: 11390026.
DOI: 10.2215/CJN.0000000000000488.
View
2.
Brunelli S, Joffe M, Israni R, Yang W, Fishbane S, Berns J
. History-adjusted marginal structural analysis of the association between hemoglobin variability and mortality among chronic hemodialysis patients. Clin J Am Soc Nephrol. 2008; 3(3):777-82.
PMC: 2386696.
DOI: 10.2215/CJN.04281007.
View
3.
Fishbane S, Berns J
. Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin. Kidney Int. 2005; 68(3):1337-43.
DOI: 10.1111/j.1523-1755.2005.00532.x.
View
4.
Lacson Jr E, Ofsthun N, Lazarus J
. Effect of variability in anemia management on hemoglobin outcomes in ESRD. Am J Kidney Dis. 2002; 41(1):111-24.
DOI: 10.1053/ajkd.2003.50030.
View
5.
Ohara T, Ikeda H, Sugitani Y, Suito H, Huynh V, Kinomura M
. Artificial intelligence supported anemia control system (AISACS) to prevent anemia in maintenance hemodialysis patients. Int J Med Sci. 2021; 18(8):1831-1839.
PMC: 7976591.
DOI: 10.7150/ijms.53298.
View